IHAM
RVMD icon

Integral Health Asset Management’s Revolution Medicines RVMD Stock Holding History

Integral Health Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$146M Buy
1,500,000
+300,000
+25% +$30.3M 6.98% 2
2025
Q4 		$95.6M Buy
1,200,000
+800,000
+200% +$52.5M 4.75% 2
2025
Q3 		$18.7M Buy
400,000
+75,000
+23% +$2.94M 1.26% 24
2025
Q2 		$12M Buy
325,000
+75,000
+30% +$2.88M 1.09% 31
2025
Q1 		$8.84M Sell
250,000
-300,000
-55% -$12.2M 0.94% 31
2024
Q4 		$24.1M Buy
550,000
+200,000
+57% +$10.1M 2.05% 11
2024
Q3 		$15.9M Buy
350,000
+25,000
+8% +$1.09M 1.79% 16
2024
Q2 		$12.6M Sell
325,000
-95,000
-23% -$3.55M 1.2% 28
2024
Q1 		$13.5M Buy
420,000
+220,000
+110% +$6.52M 1.26% 34
2023
Q4 		$5.74M Sell
200,000
-325,000
-62% -$7.81M 0.78% 54
2023
Q3 		$14.5M Buy
525,000
+169,000
+47% +$5.01M 2.01% 18
2023
Q2 		$9.52M Buy
356,000
+11,000
+3% +$270K 1.18% 35
2023
Q1 		$7.47M Buy
+345,000
New +$8.5M 1.51% 30

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Integral Health Asset Management's RVMD Position: Q1 2026 in Review

Integral Health Asset Management increased its Revolution Medicines (RVMD) stake by 25% in Q1 2026, buying an estimated $30.3M and bringing the position to 1,500,000 shares worth $146M. The position accounts for 6.98% of the portfolio, ranked #2.

Integral Health Asset Management first reported a position in RVMD in Q1 2023 and has held it in 13 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Integral Health Asset Management held 1,500,000 shares of Revolution Medicines worth $146M as of Q1 2026.
  • Integral Health Asset Management bought 300,000 Revolution Medicines shares in Q1 2026, an estimated $30.3M.
  • Revolution Medicines made up 6.98% of Integral Health Asset Management's portfolio in Q1 2026, its #2 holding.
  • Integral Health Asset Management first reported a position in Revolution Medicines in Q1 2023 and has held it in 13 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.